Clinical

Dataset Information

0

NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer

ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I/II trial to study the effectiveness of NB1011 in treating patients who have metastatic or recurrent colorectal cancer that has not responded to previous treatment.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2007222 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Clinical Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer
| 2003409 | ecrin-mdr-crc
Clinical Chemotherapy in Treating Patients With Solid Tumors
| 2002684 | ecrin-mdr-crc
Clinical PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma
| 2003447 | ecrin-mdr-crc
Clinical Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
| 2006232 | ecrin-mdr-crc
Clinical Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer
| 2003275 | ecrin-mdr-crc
Clinical Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
| 2004721 | ecrin-mdr-crc
Clinical Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer
| 2004952 | ecrin-mdr-crc
Clinical SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer
| 2006976 | ecrin-mdr-crc
Clinical Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
| 2002537 | ecrin-mdr-crc
Clinical BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
| 2006586 | ecrin-mdr-crc